Reinhard Andreesen

Q: What Schools Are Affiliated With Reinhard Andreesen

Reinhard Andreesen is affiliated with the following schools: University of Regensburg, Hannover Medical School

Reinhard Andreesen's AcademicInfluence.com Rankings

Reinhard Andreesen

Biology

#11570

World Rank

#14974

Historical Rank

Immunology

#750

World Rank

#772

Historical Rank

biology Degrees

Download Badge

Biology

Reinhard Andreesen's Degrees

PhD Immunology University of California, Berkeley
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Reinhard Andreesen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Reinhard Andreesen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inhibitory effect of tumor cell-derived lactic acid on human T cells. (2007) (1294)
Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells (2004) (524)
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. (2006) (509)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial (2012) (507)
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. (2006) (413)
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. (2014) (402)
Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. (1991) (351)
Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation (2009) (336)
Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes (2009) (317)
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. (2006) (314)
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro (2006) (306)
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. (2004) (287)
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene* (2000) (277)
Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. (1997) (277)
Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. (2009) (255)
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. (1993) (246)
Transcriptional Regulation of CHI3L1, a Marker Gene for Late Stages of Macrophage Differentiation* (2003) (233)
Treatment of Colon and Lung Cancer Patients with ex Vivo Heat Shock Protein 70-Peptide-Activated, Autologous Natural Killer Cells (2004) (227)
Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cells (2003) (226)
Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages1 (2000) (218)
Surface Phenotype Analysis of Human Monocyte to Macrophage Maturation (1990) (215)
Expression of CD68 in Non‐Myeloid Cell Types (2008) (208)
Isolation and characterization of human antigen-specific TCRαβ+ CD4-CD8- double-negative regulatory T cells (2005) (208)
lnterleukin‐8 and neutrophil activation in acute pancreatitis (1992) (205)
CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. (1998) (203)
Selective destruction of human leukemic cells by alkyl-lysophospholipids. (1978) (198)
Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. (1979) (194)
Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. (2006) (187)
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. (2006) (185)
Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. (1990) (182)
Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranes. (1983) (175)
Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients 1 (2003) (174)
Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. (2004) (173)
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. (1998) (161)
Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. (2006) (150)
Isolation of CD4+CD25+ regulatory T cells for clinical trials. (2006) (146)
Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients (2000) (146)
Comparative analysis of integrin expression on monocyte‐derived macrophages and monocyte‐derived dendritic cells (2000) (145)
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors (2003) (144)
Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. (2003) (137)
Transcription and enhancer profiling in human monocyte subsets. (2014) (136)
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. (2003) (136)
Adoptive immunotherapy of cancer using monocyte‐derived macrophages: rationale, current status, and perspectives (1998) (134)
Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. (1986) (132)
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. (2002) (132)
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation (2000) (132)
Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. (2012) (127)
Induction of human monocyte to macrophage maturation in vitro by 1,25-dihydroxyvitamin D3. (1990) (123)
Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting (1992) (119)
General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. (2010) (115)
Warburg phenotype in renal cell carcinoma: High expression of glucose‐transporter 1 (GLUT‐1) correlates with low CD8+ T‐cell infiltration in the tumor (2011) (114)
A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccocus aureus in human monocytes (1997) (103)
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. (2006) (100)
Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30). (1989) (96)
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes (2013) (95)
Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes. (2004) (94)
Interferon‐induced programmed death‐ligand 1 (PD‐L1/B7‐H1) expression increases on human acute myeloid leukemia blast cells during treatment (2014) (94)
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma (2004) (94)
Macrophage Colony‐Stimulating Factor Is Required for Human Monocyte Survival and Acts as a Cofactor for Their Terminal Differentiation to Macrophages In Vitro (1991) (89)
Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. (2000) (88)
A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. (1984) (87)
Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels (2010) (87)
The Treatment of Patients With Disseminated Malignant Melanoma by Vaccination With Autologous Cell Hybrids of Tumor Cells and Dendritic Cells (2002) (86)
Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: a case report of a patient with self-induced septicemia. (1997) (86)
Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. (2005) (85)
Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite. (2006) (85)
A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts (1984) (84)
An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. (2002) (80)
Developmental Regulation of the Cytokine Repertoire in Human Macrophages: IL‐1, IL‐6, TNF‐α, and M‐CSF (1991) (80)
New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells (2013) (80)
Destruction of human solid tumors by alkyl lysophospholipids. (1980) (79)
Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. (2006) (79)
Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell Interactions (2006) (79)
Transcription Factor Tfec Contributes to the IL-4-Inducible Expression of a Small Group of Genes in Mouse Macrophages Including the Granulocyte Colony-Stimulating Factor Receptor1 (2005) (78)
Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. (1996) (78)
Carboxypeptidase M Is Identical to the MAX.1 Antigen and Its Expression Is Associated with Monocyte to Macrophage Differentiation (*) (1995) (77)
Biological response to intravenously administered endotoxin in patients with advanced cancer. (1990) (76)
Bioluminescence and chemiluminescence - new perspectives (1987) (74)
Evaluation of C‐reactive protein, interleukin‐6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients (2006) (72)
The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations. (2014) (72)
Differentiation of Human Tumour‐associated Dendritic Cells into Endothelial‐like Cells: An Alternative Pathway of Tumour Angiogenesis (2007) (68)
Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2‐deoxy‐glucose affects effector functions (2015) (68)
Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg (2011) (63)
LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway (2004) (61)
Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR (2006) (61)
Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages (2000) (61)
Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. (2008) (60)
Secretory repertoire of HIV-infected human monocytes/macrophages. (1991) (59)
Dominant Th2 Differentiation of Human Regulatory T Cells upon Loss of FOXP3 Expression (2012) (59)
Macrophage heterogeneity and differentiation: defined serum-free culture conditions induce different types of macrophages in vitro. (1992) (59)
Selective sensitivity of chronic myelogenous leukemia cell populations to alkyl-lysophospholipids. (1979) (58)
Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. (2000) (58)
ALLOSTIMULATORY CELLS IN FRESH HUMAN BLOOD: HETEROGENEITY IN ANTIGEN‐PRESENTING CELL POPULATIONS (1993) (57)
Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation. (1983) (57)
RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells (2010) (56)
Hybrid Cell Vaccination in Metastatic Melanoma: Clinical and Immunologic Results of a Phase I/II Study (2004) (56)
Synthetic alkylphospholipid analogues: a new class of antitumor agents (1985) (55)
Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharide (1997) (54)
Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation. (2000) (54)
The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation (2008) (54)
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. (2002) (53)
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial (2007) (53)
Lysophosphatidylcholine (Lysolecithin) and its Synthetic Analogues. Immunomodulating and Other Biologic Effects (1979) (53)
Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy. (2000) (53)
Three‐dimensional co‐culture of human monocytes and macrophages with tumor cells: Analysis of macrophage differentiation and activation (1996) (52)
High Frequency of Functionally Active Melan-A–Specific T Cells in a Patient with Progressive Immunoproteasome-Deficient Melanoma (2004) (52)
Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase. (2011) (51)
Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease (2009) (50)
Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine. (1984) (49)
Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. (2001) (49)
Individual cell analysis of the cytokine repertoire in human immunodeficiency virus-1-infected monocytes/macrophages by a combination of immunocytochemistry and in situ hybridization. (1998) (46)
Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. (2002) (45)
TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation. (2013) (45)
Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. (2008) (44)
Diagnosis of Hepatic Veno-occlusive Disease by Plasminogen Activator Inhibitor-1 Plasma Antigen Levels: A Prospective Analysis in 350 Allogeneic Hematopoietic Stem Cell Recipients (2005) (43)
Molecular cloning and characterization of a human metalloprotease disintegrin--a novel marker for dendritic cell differentiation. (2000) (43)
Infection of monocytes/macrophages by HIV in vitro. (1990) (43)
Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes (1984) (43)
CD8+ T cells Reactive to Survivin Antigen in Patients with Multiple Myeloma (2007) (43)
Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System (2013) (43)
Interferon (IFN)‐γ is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN‐γ and tumour necrosis factor‐α production (2005) (42)
Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia. (1998) (41)
Comparative analysis of dendritic cells derived from blood monocytes or CD34+ hematopoietic progenitor cells. (1998) (41)
Ether lipids in the therapy of cancer. (1988) (41)
Mitoxantrone/high‐dose ara‐c and recombinant human gm‐csf in the treatment of refractory non‐hodgkin's lymphoma a pilot study (1990) (41)
Monocyte differentiation in intestine‐like macrophage phenotype induced by epithelial cells (2001) (40)
Activation of human monocyte-derived macrophages cultured on Teflon: response to interferon-gamma during terminal maturation in vitro. (1988) (40)
Anti‐inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans’ cell histiocytosis of adults (2005) (40)
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma (2007) (39)
Systematic classification of HIV biological subtypes on lymphocytes and monocytes/macrophages. (1990) (39)
Inverse regulation of the ADAM‐family members, decysin and MADDAM/ADAM19 during monocyte differentiation (2003) (39)
Retinoic acid inhibits monocyte to macrophage survival and differentiation. (1998) (39)
Molecular cloning of a novel macrophage maturation-associated transcript encoding a protein with several potential transmembrane domains. (1995) (38)
Interferon-gamma-induced expression of tissue factor activity during human monocyte to macrophage maturation. (1992) (37)
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. (2004) (36)
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma. (1990) (35)
Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non‐malignant urothelial cell lines (1998) (35)
Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease. (2007) (34)
Clinical experience with posaconazole prophylaxis – a retrospective analysis in a haematological unit (2011) (34)
Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: Diagnostic and histogenetic relevance of MS‐1 high molecular weight protein expression (1993) (34)
Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). (1995) (33)
Impact of Thrombophilic Gene Mutations and Graft-versus-Host Disease on Thromboembolic Complications after Allogeneic Hematopoietic Stem-Cell Transplantation (2004) (33)
Carboxypeptidase M as a marker of macrophage maturation (1998) (32)
Defibrotide: An endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo (2007) (32)
Reverse signalling of membrane‐integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells (2005) (32)
Dendritic Cells for Specific Cancer Immunotherapy (2001) (32)
Characterization of cells prepared by dendritic cell-tumor cell fusion. (2002) (31)
[The "classical" macrophage marker CD68 is strongly expressed in primary human fibroblasts]. (2003) (31)
Platelets induce monocyte differentiation in serum‐free coculture (1998) (31)
Expression of retinoid receptors during human monocyte differentiation in vitro. (2000) (30)
Lysophosphatidylcholine (lysolecithin) and its synthetic analogues. Immunemodulating and other biologic effects (2005) (29)
HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid. (1986) (29)
Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84. (2000) (29)
Regression of nonresectable inflammatory myofibroblastic tumours after treatment with nonsteroidal anti‐inflammatory drugs (2004) (29)
High frequency of functionally active Melan-A specific T cells in a patient with progressive immunoproteasome-deficient melanoma (2004) (29)
Inhibition of in vitro differentiation of human monocytes to macrophages by lipopolysaccharides (LPS): phenotypic and functional analysis. (1991) (29)
Expression and Function of Homing‐Essential Molecules and Enhanced In Vivo Homing Ability of Human Peripheral Blood‐Derived Hematopoietic Progenitor Cells after Stimulation with Stem Cell Factor (2004) (29)
Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft-vs.-host disease of the intestinal tract. (2011) (29)
Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft‐versus‐host disease (2010) (28)
CD84 expression on human hematopoietic progenitor cells. (2003) (28)
Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. (2012) (27)
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial (2012) (27)
Variations in 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation (2004) (27)
Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide. (1996) (27)
Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages. (1991) (26)
Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results. (1991) (26)
Isolated cerebral manifestation of Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges (2011) (25)
Identification of genes expressed in tumor-associated macrophages. (2003) (25)
Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancer. (1995) (25)
Adoptive Immunotherapy with Tumor‐Cytotoxic Macrophages Derived from Recombinant Human Granulocyte‐Macrophage Colony‐Stimulating Factor (rhuGM‐CSF) Mobilized Peripheral Blood Monocytes (1997) (25)
Interleukin‐10 Promotes NK Cell Killing of Autologous Macrophages by Stimulating Expression of NKG2D Ligands (2010) (25)
Microculture assay for human macrophage maturation in vitro. Cell-ELISA analysis of differentiation antigen expression. (1988) (25)
Differential effects of cell adherence on LPS-stimulated cytokine production by human monocytes and macrophages. (1997) (25)
Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids. (1982) (25)
Bone morphogenetic protein (BMP)-7 but not BMP-2 and BMP-4 improves maintenance of primitive peripheral blood-derived hematopoietic progenitor cells (HPC) cultured in serum-free medium supplemented with early acting cytokines. (2007) (25)
Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib (2006) (24)
Adoptive immunotherapy with autologous macrophages: current status and future perspectives. (1991) (24)
Defective monocyte-to-macrophage maturation in patients with aplastic anemia. (1989) (24)
The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the α and β chains (p55 and p75) (1992) (24)
Adoptive T cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma: a phase I clinical study (2004) (24)
Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease (2009) (24)
EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells (2009) (24)
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial (2017) (23)
Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel (2011) (23)
Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids (2010) (23)
Genomic organization of the human gene HEP27: alternative promoter usage in HepG2 cells and monocyte-derived dendritic cells. (2002) (22)
C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation (2006) (22)
The interaction of liposomes with cells: the relation of cell specific toxicity to lipid composition. (1980) (22)
Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L‐selectin‐mediated homing to peripheral LN (2009) (22)
Alkyl-lysophospholipid induced suppression of human lymphocyte response to mitogens and selective killing of lymphoblasts. (1980) (22)
Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (2004) (22)
The membrane-bound ectopeptidase CPM as a marker of macrophage maturation in vitro and in vivo. (2000) (22)
Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis (2011) (22)
Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates. (1992) (21)
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association (2018) (21)
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients (2017) (21)
Direct evidence of endothelial injury during cardiopulmonary bypass by demonstration of circulating endothelial cells (2006) (20)
Isolation and transplantation of allogeneic pulmonary endothelium derived from GFP transgenic mice. (2003) (20)
NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters. (2008) (20)
Expression of heme oxygenase-1 protects endothelial cells from irradiation-induced apoptosis. (2005) (20)
A Role for CD54 (Intercellular Adhesion Molecule-1) in Leukocyte Recruitment to the Lung During the Development of Experimental Idiopathic Pneumonia Syndrome (2005) (20)
Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis. (2014) (20)
Reduced tumor‐antigen density leads to PD‐1/PD‐L1‐mediated impairment of partially exhausted CD8+ T cells (2012) (19)
Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells (2003) (18)
The Impact of a Tumor Diagnosis on Patients' Attitudes toward Advance Directives (2014) (18)
Granulocyte–macrophage colony‐stimulating factor modulates lipopolysaccharide (LPS)‐binding and LPS‐response of human macrophages: inverse regulation of tumour necrosis factor‐α and interleukin‐10 (1999) (17)
Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia (1999) (17)
111In‐oxine labelling of tumour‐cytotoxic macrophages generated in vitro from circulating blood monocytes: An in vitro evaluation (1995) (16)
Monoclonal antibodies against differentiation antigens on human macrophages. (1985) (16)
Human macrophage maturation and heterogeneity: Restricted expression of late differentiation antigens in situ (1988) (15)
A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes. (1991) (15)
Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia (2011) (15)
Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule. (2007) (15)
Macrophages in Tumor Biology (2002) (14)
Isolation of intact genomic DNA from FOXP3‐sorted human regulatory T cells for epigenetic analyses (2010) (14)
Regulation of cellular retinoic acid binding protein (CRABP II) during human monocyte differentiation in vitro. (1998) (14)
Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368). (1983) (14)
Modular therapy approach in metastatic castration-refractory prostate cancer (2010) (14)
Large-scale production of human tumorcytotoxic macrophages grown from blood monocytes of cancer patients. (1991) (14)
Molecular cloning of a 1alpha,25-dihydroxyvitamin D3-inducible transcript (DDVit 1) in human blood monocytes. (1997) (13)
Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry (2012) (13)
The human lysozyme gene undergoes stepwise demethylation during phagocyte maturation (1997) (13)
Papillary thyroid cancer associated with syndrome of inappropriate antidiuresis: a case report (2010) (13)
Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity (2005) (13)
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation (2005) (13)
Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation. (2007) (12)
Analysis of macrophage subsets in renal allograft biopsies with new monoclonal antibodies. (1990) (12)
Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia (2010) (12)
Generation of Cytokines in Human Visceral Leishmaniasis: Dissociation of Endogenous TNF-α and IL-1β Production (1991) (12)
Expression of macrophage products after in vitro infection of human monocytes/macrophages with HIV. (1993) (12)
Defective monocyte to macrophage maturation in human immunodeficiency virus infection. (1990) (12)
Short- and Long-Term Tolerability Study of the Thioether Phospholipid Derivative Ilmofosine in Cancer Patients1 (1989) (12)
Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation (2003) (12)
Variations in 1 alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. (2004) (12)
A case of Waldenstroem's disease with a monoclonal IgM antiphospholipid antibody (2002) (11)
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan (2014) (11)
The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75). (1992) (11)
Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor (2012) (11)
Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome (1993) (11)
A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC). (2011) (10)
Cytokine expression of HIV-infected monocytes/macrophages at the single-cell level. (1994) (10)
G to C transition at position -173 of MIF gene of the recipient is associated with reduced relapse rates after allogeneic stem cell transplantation. (2009) (10)
Pericarditis after High-Dose Chemotherapy: More Frequent than Expected? (2006) (10)
[Preventive crisis management in general outpatient palliative care - prospectively cross-sectional study of General Practitioners in Eastern Bavaria]. (2011) (10)
Peripheral Dendritic Cell Chimerism in Allogeneic Hematopoietic Stem Cell Recipients (2005) (9)
Differentiation of hematopoietic progenitor cells towards the myeloid and B‐lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines (2006) (9)
Beta-tubulin and P-glycoprotein: major determinants of vincristine accumulation in B-CLL cells. (1995) (9)
Remission induction therapy: the more intensive the better? (2001) (9)
The polysulphated polyxylan Hoe/Bay-946 inhibits HIV replication on human monocytes/macrophages. (1990) (8)
Monocyte differentiation and accessory function: different effects on the proliferative responses of an autoreactive T cell clone as compared to alloreactive or antigen-specific T cell lines and primary mixed lymphocyte cultures. (1994) (8)
In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation (2004) (8)
Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophages. (1995) (7)
Anti-Inflammatory, Immuno-Modulatory and Angiostatic Treatment As Third-Line Therapy for Multiple Myeloma (MM) – a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan (phase I/II) (2012) (7)
Regulation of Neopterin Secretion during Human Monocyte to Macrophage Differentiation in Vitro (1990) (7)
Differentiation of Human Monocytes In Vitro: A Model of Macrophage Ontogeny (1994) (7)
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes (2013) (7)
Isolation, Characterization and Cultivation of Human Monocytes and Macrophages (2002) (7)
Anti-inflammatory therapy combined with angiostatic scheduling of chemotherapy in advanced biliary tract cancer, hepatocellular carcinoma and gastric cancer. (2004) (6)
Surface antigen analysis of human macrophage maturation and heterogeneity (1986) (6)
Acute Deterioration Of Charcot‐Marie‐Tooth Disease IA (CMT IA) Following 2 MG Of Vincristine Chemotherapy (2001) (6)
Metagenomic analysis of the stool microbiome in patients receiving allogeneic SCT: Loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal GvHD (2014) (6)
Enhancement of spontaneous and lymphokine activated human macrophage cytotoxicity by hyperthermia (1983) (6)
Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide (2007) (6)
Activation of lymphocytes inhibits human monocyte to macrophage differentiation. (2001) (6)
Role of cells and mediators for granuloma formation in pulmonary sarcoidosis (1989) (5)
Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2 (1987) (5)
Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta production. (1991) (5)
Secretion of Colony-Stimulating Factor for Macrophages (M-CSF) and Granulocyte/Macrophages (GM-CSF) is Developmentally Regulated in Human Macrophages (1990) (5)
The expression of specific differentiation antigens on macrophages infiltrating rejecting renal allografts. (1987) (5)
Origin of Reed-Sternberg cells in Hodgkin's disease. (1989) (5)
1000 Pioglitazone and rofecoxib combined with angiostatic scheduling of chemotherapy in far advanced malignancies (2003) (5)
Macrophage-directed tumour immunotherapy revisited--past and future of an old doctor's dilemma. (1993) (5)
Morphological effects of an antitumor agent on human esophageal carcinoma cells in vitro. (1980) (5)
Tumor-Derived Lactic Acid Modulates Dendritic Cell Activation and Differentiation. (2004) (5)
Restricted HIV type 1 replication under serum-free culture conditions in human monocyte-derived macrophages. (1998) (5)
284 Does effective chemotherapy for metastatic colorectal cancer (CC) improve quality of life (QL)? Preliminary results of a randomized phase II-study using the eortc QLQ C30 (1995) (4)
Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid. (1983) (4)
Interleukin-1 production of differently stimulated Kupffer cells isolated from murine and human livers (1989) (4)
Respiratory burst formation by human macrophages at different stages of maturation: dissociation of the generation of particular oxygen radicals (1987) (4)
Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids (1985) (4)
NOD2/CARD15 Variants of Donor and Recipient as Critical Risk Factors for the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation. (2005) (4)
Recipient NOD 2 / CARD 15 status affects cellular infiltrates in human intestinal graft-versus-host disease (2010) (4)
Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type (2004) (3)
Adoptive therapy with monocyte‐derived macrophages in the setting of high‐dose chemotherapy and peripheral blood stem cell transplantation (2002) (3)
Human genome meeting 2016 (2016) (3)
SCF modulates organ distribution and hematopoietic engraftment of CB-derived pluripotent HPC transplanted in NOD/SCID mice. (2006) (3)
Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony‐stimulating factor and erythropoietin (2007) (3)
Human macrophage maturation in vitro: Expression of functional transferrin binding sites of high affinity (1988) (3)
Adoptive T Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients with Cancer: A Phase I Clinical Study. (2005) (3)
Reactive to Survivin Antigen in Patients withMultiple Myeloma (2007) (3)
[Unusual skin alterations in a 72-year-old patient with multiple myeloma]. (2012) (3)
[The ultrasound centre as a medically and economically relevant alternative--a report of the Regensburg experience]. (2000) (3)
Loss of FOXP3 Expression and Emergence of Cytokine-Producing Cells after In Vitro Expansion of Human CD4+CD25+CD127 - Regulatory T Cells. (2007) (3)
Pioglitazone and Rofecoxib Combined with Angiostatically Scheduled Capecitabine in Far-Advanced Hepatobiliary Carcinoma (2010) (3)
Anti-tumor effects of bacterial endotoxin (lipopolysaccarides, Lipid A) and synthetic lysolecithin analogues. Study week on the role of non-specific immunity in the prevention and treatment of cancer (1979) (3)
,25-dihydroxyvitamin D3 by human dendritic cells α -hydroxylase and production of 1 α Regulation of 25-hydroxyvitamin D3-1 (2013) (3)
Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer. (2016) (3)
Generation of tumorcidal macrophages and direct selective destruction of tumor cells by membrane active adjuvants. (1983) (3)
Induction of complete remission in metastatic hormone-refractory prostate cancer: A combined anti-inflammatory therapy approach (2007) (3)
[In vitro and in vivo studies with interleukin 2 (IL-2) and various immunostimulants in a patient with AIDS]. (1985) (2)
Macrophages: the function of phagocytosis (1996) (2)
Metronomic chemotherapy plus/minus antiinflammatory treatment in far-advanced melanoma: A randomized multi-institutional phase II trial (2005) (2)
[Inhibition of thrombocyte aggregation as a therapeutic principle. Review of the literature and currently approved thrombocyte aggregation inhibitors]. (2000) (2)
[Knee joint hematomas not due to accidents]. (1970) (2)
299: The role of SNPs within receptors of innate immunity in outcome following allogeneic stem cell transplantation: Synergism between TLR5-stop and NOD2/CARD15? (2007) (2)
Multifocal reversible epithelial dysplasia mimicking carcinoma in situ after conditioning therapy with busulfan and cyclophosphamide (1999) (2)
11: Risk Factor Analysis for the Development of Restrictive and Obstructive Pulmonary Function Changes After Allogeneic Stem Cell Transplantation (2008) (2)
Treosulfan-Based Tandem High-Dose Chemo-Immuno- Therapy with Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive B-Cell Lymphomas. (2005) (2)
Terminal maturation and cytotoxic effector cell activation of human macrophages in vitro on hydrophobic teflon: surface antigen analysis with 145 anti-myeloid workshop monoclonal antibodies (1987) (2)
IMMUNOMONITORING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: 420 (2004) (2)
Myeloablative chemotherapy and peripheral blood stem cell transplantation vs. consolidation therapy of acute myelogenous leukemia in first remission (1998) (2)
Experimental studies with alkyl-lysophospholipids in soft tissue sarcomas (1983) (2)
Adoptive Transfer of Autologous Cytotoxic Macrophages Grown from Blood Monocytes. A New Approach to Cancer Immunotherapy (1993) (2)
Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo- therapy (2004) (1)
anemia Defective monocyte-to-macrophage maturation in patients with aplastic (2011) (1)
Immunomodulation by IFN-γ in patients with resistant infections and accompanying bronchiolitis obliterans following allo-SCT (2011) (1)
Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany (2010) (1)
[Practical experiences in the expert testimony on meniscus injuries]. (1956) (1)
Targeted anti-inflammatory and angiostatic therapy in pretreated patients with advanced hepatocellular carcinoma (2008) (1)
HLA-DRantigens on humanmacrophages from bronchoalveolar lavage fluid (1986) (1)
Genetic Instability in Remission Hematopoiesis Is Different from That in AML Blasts: A New Diagnostic Tool to Study Biology of AML. (2004) (1)
Developmental regulation of granulocyte-macrophage colony-stimulating factor production during human monocyte-to-macrophage maturation (1992) (1)
Only MHC-Identical Donor CD4 + CD25 + Regulatory T Cells Convey Full Protection from Lethal Graft-Versus-Host Disease (2008) (1)
Regression of eosinophil counts after diagnosis of chronic graft-versus-host disease as a potential marker for improved clinical outcome. (2014) (1)
NOD2/CARD15 Mutations Associate With Transplant-related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 209 Recipient/Donor Pairs (2006) (1)
Inhibitory Effects of Lactic Acid on Human Antigen-Specific CD8+ T-Cells. (2004) (1)
Enhanced verapamil mediated vincristine accumulation in cycling human B-CLL cells (1992) (1)
Efficient Treatment of Murine Acute Graft-Versus-Host Disease with In Vitro Expanded CD4+CD25+ Regulatory T Cells (2011) (1)
Phenotypic and functional analysis of human Kupffer cells: a preliminary report (1986) (1)
Receptorthe Granulocyte Colony-Stimulating Factor of Genes in Mouse Macrophages Including IL-4-Inducible Expression of a Small Group Transcription Factor Tfec Contributes to the (2005) (1)
Only Naive CD45RA+CD4+CD25high T Cells from Human Peripheral Blood Give Rise to Homogeneous Regulatory T Cell Lines. (2006) (1)
Effect of anti-inflammatory therapy in patients with metastatic renal cell carcinoma on clinical response. (2006) (1)
Role of Mitoxantrone, High-Dose Cytosine Arabinoside, and Recombinant Human GM-CSF in Aggressive Non-Hodgkin’s Lymphoma (1992) (1)
Systems-Directed Therapy in Metastatic Castration-Resistent Prostate Cancer (CRCP) (2010) (1)
[Lambert-Eaton syndrome and Schwartz-Bartter syndrome in small cell bronchial cancer. Simultaneous manifestation of two paraneoplastic syndromes as an indication of a systemic malignant disease]. (1993) (1)
732 Modulation of weekly high dose infusional 5-fluorouracil (FU) by leucovorin (LV), α-interferon (IFN) or LV plus IFN in advanced colorectal cancer. Results of a multicenter randomized trial of the AIO (1995) (1)
[ORIGIN, EXPERT TESTIMONY AND THERAPY OF SCAPHOID BONE PSEUDARTHROSIS OF THE HAND]. (1965) (1)
Molecular mechanisms modulating vincristine accumulation and cytotoxicity in chronic lymphatic leukemia of B-cell type (1995) (1)
A multimodal treatment approach including high-dose chemotherapy in very advanced gastric cancer: evidence for control of metastatic disease (2003) (1)
Long-Term Results of Combined Modularized, Immune-Modulatory, Angiostatic, and Antiinflammatory Therapy in Systemically Pre-Treated Multi-Systems Langerhans Cell Histiocytosis (2013) (1)
Peripheral Blood Stem Cell Transplantation During Postremission Treatment of de Novo Acute Myelogenous Leukemia (1998) (1)
double negative regulatory T cells + CD4-CD8- β α Isolation and characterization of human antigen-specific TCR (2013) (1)
PAF-related analogues and their interaction with immunocomponent cells (1987) (0)
Thrombotic disease in cancer patients1 (2009) (0)
Cytotoxic activity in the serum of a patient with metastasizing nephroblastoma given intravenous infusions of alkyl-lysophospholipids in a phase I study (1982) (0)
Graft-Versus-Host Disease Impairs Early B Lymphopoiesis in the Bone Marrow (2011) (0)
Compassionate Use of Combined Anti-Inflammatory and Angiostatic Treatment as Third-Line Therapy in Eight Patients with Multiple Myeloma – a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan. (2009) (0)
DDVit1 - A possible differentiation factor for human monocytic and enterocytic cells (1997) (0)
Unusual manifestations of acute leukemia. Case 2. Leukemia and rash: paraneoplastic or drug-induced? (2000) (0)
[Symptomatic leukemic infiltration of the lung in acute myeloid leukemia]. (1998) (0)
Generation and enrichment of antigen-specific cytotoxic t lymphocytes for adoptive transfer in tumor immunotherapy (2000) (0)
Clinical case Acute deterioration of Charcot-Marie-Tooth disease IA (CMTIA) following 2 mg of vincristine chemotherapy (2005) (0)
Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan (2015) (0)
Expression of vitamin D-receptor and retinoid receptors during human monocyte differentiation in vitro. (1999) (0)
Validation of the Lung Function Score as a Valuable Parameter for the Assessment of Chronic Graft-Versus-Host Disease and Clinical Outcome After Allogeneic Haematopoietic Cell Transplantation. (2009) (0)
In Vitro Monitoring of Defibrotide Prophylaxis for Endothelial Complications Following Allogeneic Stem Cell Transplantation. (2006) (0)
Defibrotide, an Endothelium Protecting and Stabilizing Drug, Has Anti-Angiogenic Potential In Vitro and In Vivo. (2005) (0)
An Alternative Transcript of the Human GM-CSF Receptor Alpha Chain Lacking the Signal Sequence Is Found in AML Blasts and Normal Controls (1997) (0)
Prognostic impact of genetic instability in CD 34 positive hematopoietic progenitor cells from patients with AML in first complete remission (2003) (0)
Monocyte/Macrophage Activation by Immunostimulators (1996) (0)
Donor -173 G/C Polymorphism of Macrophage Migration Inhibitory Factor Gene Is Associated with the Development of Chronic Graft Versus Host Disease. (2006) (0)
The α2-macroglobulin receptor is a monocyte differentiation antigen strongly upregulated during macrophage maturation (1995) (0)
Cellular Immunotherapy of Cancer: Adoptive Transfer of Monocyte-Derived Tumorcytotoxic Macrophages (1998) (0)
Expression and release of IL-2 receptor alpa- and beta-chain (CD25 and p75) in human monocytes and macrophages (1992) (0)
Intestinal epithelial cells induce the specific differentiation of intestinal macrophages (1998) (0)
Epigenetic Regulation of the Dendritic Cell Marker Gene MADDAM /ADAM19. (2004) (0)
26: A critical contribution of donor -173G/C polymorphism of macrophage migration inhibitory factor gene to the development of chronic graft versus host disease (2007) (0)
Delayed Onset of T Cell-Mediated Xenogeneic Disease in Rag2−/− γc−/− mice after Co- Transplantation of in Vitro Expanded Human CD4+CD25highCD45RA+ Regulatory T Cells (2008) (0)
Expression of Proteinase Inhibitor-9 in Primary AML Blasts and Its Regulation by Interferon-γ: A Potential Immune Escape Mechanism after Allogeneic Stem Cell Transplantation. (2006) (0)
[Practical measures in the treatment of burns]. (1961) (0)
ExpressionRegulatory T Cells upon Loss of FOXP3 Dominant Th2 Differentiation of Human (2011) (0)
Membrane expression of heat shock protein 70 (Hsp70) in hematological malignancies (2001) (0)
[Space occupying lesion in the anterior mediastinum in a patient with Basedow disease and previously diagnosed osteosarcoma]. (2008) (0)
Phenotypic and functional characterization of human peritoneal macrophages derived from cirrhotic ascites (1989) (0)
Genome-Wide Profiling of Epigenetic and Transcription Factor Regulation In Human Macrophage Differentiation (2010) (0)
Lymphopenia-Associated CD4+ T Cell-Mediated Colitis Correlates with Homeostatic but Not with Endogenous Proliferation. (2005) (0)
[New in vitro test systems]. (1995) (0)
[Paget's disease, spontaneous fracture and sarcoma]. (1955) (0)
Isolation of Human CD4 + CD25 + T Cells with Regulatory Capacity for Clinical Trials. (2004) (0)
[Proposal for simplification of occupational disease no. 42]. (1969) (0)
Low-Dose Cyclosporin A Does Not Abrogate the Suppressive Function of In Vitro Expanded Human CD4 + CD25 + Regulatory T Cells. (2006) (0)
1,25- dihydroxyvitamin D3 Induction of human monocyte to macrophage maturation in vitro by (2011) (0)
Macrophages - Differentiation of Human Monocytes into Macrophages in vitro (1994) (0)
Ether-lipids and cell immunity. A potential role for antitumor activity (1987) (0)
Intestinal Microbiota: From Inflammatory Bowel Disease to Bone Marrow Transplantation (2012) (0)
ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation (2009) (0)
Inclusion of High-Dose Treosulfan Followed by Autologous Transplantation in the Tandem Transplantation for Patients with Multiple Myeloma <60 Years. (2007) (0)
[Historical development and principles of occupational disease 42 (miner's meniscus)]. (1963) (0)
Secretion and Glycolysis of Human Monocytes Lactic Acid and Acidification Inhibit TNF (2011) (0)
The Macrophage 1990 (Part II): Part II: Macrophage and Viral Infection, Macrophages as Tumor Cytotoxic Effector Cells, Macrophage Biochemistry and Molecular Biology. 1990 Annual Conference of the Upper Rhine Universities, Freiburg, September 1990: Selected Papers and Abstracts (1991) (0)
Antibacterial activity of monocytes and macrophages against Staphylococcus aureus and Klebsiella pneumoniae in combination with Latamoxef (1987) (0)
Transplantation Strategies for High Risk Acute Myeloid Leukemias (2003) (0)
to macrophage maturation (1996) (0)
Effective Treatment of Acute GvHD After Haploidentical BMT With in vitro Expanded Murine CD4+CD25+ Regulatory T Cells (2011) (0)
via Bidirectional Signaling Receptor Family, Induces Monocyte Activation CD137 (ILA/4-1BB), a Member of the TNF (2013) (0)
[Is the healing of malacia of the semilunar bone possible?]. (1970) (0)
Targets of Aberrant Hypermethylation in Myeloid Leukemia Genome-Wide Profiling of CpG Methylation Identifies Novel (2006) (0)
Generation of large numbers of tumorcytotoxic macrophages grown from blood monocytes of cancer patients for use in immunotherapy trials (1990) (0)
Stem cell mobilization II - critical issues (1993) (0)
Hsp70-peptide activated autologous NK cells in the immunotherpay of cancer — a clinical pilot study (2001) (0)
Is Survivin a Possible Target Antigen for Cellular Immunotherapy in Multiple Myeloma (2005) (0)
[Using activated macrophages for tumor therapy? Priv.-Doz. Dr. R. Andreesen presents new perspectives in cancer research. Interview by Elisabeth B. Moosmann]. (1991) (0)
The Macrophage 1990 (Part I): Part I: Macrophage Heterogeneity and Differentiation, Macrophages in the Pathogenesis of Disease, Macrophages and Antimicrobial Defense. 1990 Annual Conference of the Upper Rhine Universities, Freiburg, September 1990: Selected Papers and Abstracts (1991) (0)
Monocyte-Derived Cells in Adoptive Immunotherapy of Cancer: Facts and Perspectives (1997) (0)
human monocytes into macrophages expression are developmentally regulated during differentiation of 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor (2011) (0)
[Practical evaluation in therapy of severe burns caused by explosions in mining]. (1952) (0)
Profiling of Aberrant DNA Methylation In AML Reveals Subclasses of CpG Islands with Epigenetic or Genetic Association (2010) (0)
Low level replication of HIV-1 in human macrophages under serum-free conditions - a model for HIV-1 latency (1998) (0)
G to C transition at position -173 of MIF gene of the recipient is associated with improved outcome after allogeneic stem cell transplantation (2008) (0)
ExpressionT Cells upon Loss of FOXP3 Dominant Th2 Differentiation of Human (2013) (0)
The Macrophage 1992: European Conference on Basic and Clinical Aspects of Macrophage Biology, Regensburg, September 1992: Abstracts (1992) (0)
Oligotide, a Defibrotide Derivative, Protects Human Microvascular Endothelial Cells Against Fludarabine-Induced Activation, Damage and Allogenicity. (2004) (0)
Altered levels of α und β tubulins in B-CLL cells: implications for VCR accumulation (1995) (0)
Phenotype of Hodgkin Cells. Expression of the Tac-Antigen and Other Determinants (1986) (0)
Indicators of disease progression. I. Relations to viral cultures on lymphocytes and macrophages and to a decrease of serum cholesterol (1990) (0)
[Current status of tetanus prophylaxis]. (1957) (0)
indoleamine 2,3-dioxygenase allogeneic stem cell transplantation and indicates activation of Tryptophan catabolism is associated with acute GVHD after human (2012) (0)
[Not Available]. (1957) (0)
Thromboembolische Erkrankungen in der Hämatologie und Onkologie / Thrombotic disease in cancer patients (2009) (0)
MonocytesSecretion and Glycolysis of Human Lactic Acid and Acidification Inhibit TNF (2009) (0)
[Meniscopathy as occupational disease (author's transl)]. (1975) (0)
NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs. (2004) (0)
P-018 Exome-sequencing identifies acquired mutations in ASXL1, PHF6 and DOCK5 as secondary genetic events in a case of germline GATA2-mutation (2013) (0)
Adoptive immunotherapy of cancer with autologous activated macrophages (1991) (0)
[Development of a screening workflow to identify patient needs in an interdisciplinary oncological day clinic]. (2021) (0)
Human macrophage (MO) maturation and heterogeneity: expression of myeloid differentiation antigens on resident kidney MO (dendritic cells) and activated tissue MO infiltrating rejecting renal allograft (1987) (0)
[Frequency and therapy of tetanus in cases of trauma in miners during the day]. (1956) (0)
Azithromycin Reduces the Severity of Non-Infectious Lung Injury After Experimental Hematopoietic Stem Cell Transplantation (2011) (0)
[Plaster of Paris therapy in fresh leg fractures and bone grafting without foreign body in delayed callus formation]. (1953) (0)
Ether-lipids and Cellular Immunity. A Role for Antitumor Activity (1988) (0)
The Interleukin-2 Receptor (CD25 and p75) in Human Monocytes and Macrophages (1992) (0)
[New and old findings on the problem of meniscal evaluation]. (1961) (0)
979 Antiangiogenetic therapy with pioglitazone, rofecoxib and metronomic trofosfamide in advanced malignant vascular tumors (2003) (0)
Treatment of High Grade B-Cell Lymphoma with Chemotherapy Plus Rituximab: A Survival Benefit Can Be Demonstrated in the Routine Data of a Regional Cancer Registry (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Reinhard Andreesen?

Reinhard Andreesen is affiliated with the following schools:

Reinhard Andreesen's Academic­Influence.com Rankings